GSE14520 dataset from the GEO database was downloaded [10]. The risk score for each included patient was calculated with the same prognostic gene-signature based model. Next, the ROC curve and the Kaplan–Meier curve were used to test the predictive value of the prognostic gene signature. The mRNA expression of the genes in the prognostic gene signature was analyzed in HCC and non-tumor tissue using the Wilcoxon signed-rank test. The two-sided P < 0.05 was considered statistically significant. The protein expression of the genes in the prognostic gene signature was explored in the Human Protein Atlas (http://www.proteinatlas.org) online database.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.